z-logo
Premium
Pre‐treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma
Author(s) -
Lambert Nathalie,
Guiddir Tamazoust,
Amat Flore,
Just Jocelyne
Publication year - 2014
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/pai.12306
Subject(s) - medicine , omalizumab , allergy , humanities , asthma , pediatrics , immunology , immunoglobulin e , art , antibody

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here